Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy
Open Access
- 30 October 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (45)
Abstract
Diabetic retinopathy (DR) is a neurovascular complication of diabetes. Recent investigations have suggested that early degeneration of the neuroretina may occur prior to the appearance of microvascular changes; however, the mechanisms underlying this neurodegeneration have been elusive. Microglia are the predominant resident immune cell in the retina and adopt dynamic roles in disease. Here, we show that ablation of retinal microglia ameliorates visual dysfunction and neurodegeneration in a type I diabetes mouse model. We also provide evidence of enhanced microglial contact and engulfment of amacrine cells, ultrastructural modifications, and transcriptome changes that drive inflammation and phagocytosis. We show that CD200-CD200R signaling between amacrine cells and microglia is dysregulated during early DR and that targeting CD200R can attenuate high glucose-induced inflammation and phagocytosis in cultured microglia. Last, we demonstrate that targeting CD200R in vivo can prevent visual dysfunction, microglia activation, and retinal inflammation in the diabetic mouse. These studies provide a molecular framework for the pivotal role that microglia play in early DR pathogenesis and identify a potential immunotherapeutic target for treating DR in patients.Keywords
Funding Information
- HHS | National Institutes of Health (R01 EY019287)
- HHS | National Institutes of Health (P30 EY02687)
- Jeffery T. Fort Innovation Fund (GF0003776)
- Siteman Retina Research Fund (GF0012047)
- Retina Associates Research Fund (GF0010289)
- Research to Prevent Blindness (RPB Unrestricted Grant)
- HHS | National Institutes of Health (T32 EY013360)
- VitreoRetinal Surgery Foundation (GR0023118)
- WashU | McDonnell Center for Cellular and Molecular Neurobiology, Washington University in St. Louis (GF0011083)
- HHS | National Institutes of Health (F30 DK130282)
- HHS | National Institutes of Health (T32 GM07200)
- Research to Prevent Blindness (RPBCDA)
- HHS | National Institutes of Health (UL1 TR002345)
- Bayer Retina Award in Japan (Award)
- International Retinal Research Foundation (Award)
- Japan Society for the Promotion of Science Overseas (Research Fellowship)
This publication has 80 references indexed in Scilit:
- CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseJournal of Neuroinflammation, 2011
- Involvement of the CD200 receptor complex in microglia activation in experimental glaucomaExperimental Eye Research, 2011
- Krüppel-Like Factor KLF10 Is a Link between the Circadian Clock and Metabolism in LiverMolecular and Cellular Biology, 2010
- CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple SclerosisThe Journal of Neuroscience, 2010
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2009
- Role of Steroids in the Management of Diabetic Macular Edema and Proliferative Diabetic RetinopathySeminars in Ophthalmology, 2009
- Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory responseBMC Medical Genomics, 2008
- CD200 Ligand–Receptor Interaction Modulates Microglial ActivationIn VivoandIn Vitro: A Role for IL-4Journal of Neuroscience, 2007
- Death of Retinal Neurons in Streptozotocin-Induced Diabetic MiceInvestigative Ophthalmology & Visual Science, 2004